Title:
European Medicines Agency announces a review of aliskiren-containing medicines
Product:
Rasilamlo, Rasilez, Rasilez HCT, Rasitrio, Riprazo, Riprazo HCT, Sprimeo, Sprimeo HCT
Issue:
The European Medicines Agency has started a review of aliskiren-containing medicines following termination of ALTITUDE study and has provided interim advice while review is ongoing.
European Medicines Agency - press release